| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S00534-007-1295-5 |
| P698 | PubMed publication ID | 18392703 |
| P2093 | author name string | Yasuhiko Sugawara | |
| Sumihito Tamura | |||
| P2860 | cites work | Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose | Q29547886 |
| The prevalence of hepatitis C virus infection in the United States, 1999 through 2002 | Q29619974 | ||
| Living donor liver transplantation to patients with hepatitis C virus cirrhosis | Q34017608 | ||
| Pegylated-interferon alpha 2b and ribavirin for recurrent hepatitis C after liver transplantation: From a Canadian experience to recommendations for therapy | Q42993590 | ||
| A pilot study of combination therapy with ribavirin plus interferon alfa for interferon alfa-resistant chronic hepatitis C. | Q43036080 | ||
| Results of retransplantation for recurrent hepatitis C. | Q44675034 | ||
| Splenectomy and preemptive interferon therapy for hepatitis C patients after living-donor liver transplantation. | Q50577446 | ||
| P433 | issue | 2 | |
| P921 | main subject | liver transplantation | Q1368191 |
| P304 | page(s) | 111-123 | |
| P577 | publication date | 2008-04-06 | |
| P1433 | published in | Journal of Hepato-Biliary-Pancreatic Surgery | Q15750952 |
| P1476 | title | Treatment strategy for hepatitis C after liver transplantation. | |
| P478 | volume | 15 |
| Q34340293 | Antiviral treatment for hepatitis C virus infection after liver transplantation |
| Q31153267 | Impact of donor and recipient single nucleotide polymorphisms of IL28B rs8099917 in living donor liver transplantation for hepatitis C |
| Q40400190 | Outcomes of treatment with daclatasvir and asunaprevir for recurrent hepatitis C after liver transplantation. |
| Q43224173 | The benefits of interferon treatment in patients without sustained viral response after living donor liver transplantation for hepatitis C. |
Search more.